MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 62 filers reported holding MEI PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $132,000 | -75.9% | 50,000 | -71.5% | 0.08% | -84.1% |
| Q3 2020 | $548,000 | -55.1% | 175,560 | -40.6% | 0.52% | -59.9% |
| Q2 2020 | $1,221,000 | -14.4% | 295,560 | -66.6% | 1.29% | -17.3% |
| Q1 2020 | $1,426,000 | -32.0% | 885,560 | +4.7% | 1.56% | -22.9% |
| Q4 2019 | $2,097,000 | +47.6% | 845,560 | 0.0% | 2.02% | +26.3% |
| Q3 2019 | $1,421,000 | -73.0% | 845,560 | -59.8% | 1.60% | -73.2% |
| Q2 2019 | $5,254,000 | -50.5% | 2,101,533 | -39.2% | 5.97% | -39.5% |
| Q1 2019 | $10,620,000 | +16.3% | 3,459,124 | 0.0% | 9.86% | -11.0% |
| Q4 2018 | $9,132,000 | -42.4% | 3,459,124 | -6.0% | 11.08% | -24.4% |
| Q3 2018 | $15,855,000 | -8.6% | 3,678,600 | -16.4% | 14.66% | +139.2% |
| Q2 2018 | $17,338,000 | – | 4,400,439 | – | 6.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |